<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED FINANCIAL STATEMENTS OF BIOGEN, INC. AND SUBSIDIARIES FOR THE YEAR ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH ANNUAL REPORT ON FORM 10K FOR THE PERIOD ENDED DECEMBER 31, 1998. </LEGEND> <MULTIPLIER> 1,000 <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> JAN-01-1998 <PERIOD-END> DEC-31-1998 <EXCHANGE-RATE> 1 <CASH> 25,445 <SECURITIES> 491,469 <RECEIVABLES> 102,923 <ALLOWANCES> 1,642 <INVENTORY> 35,865 <CURRENT-ASSETS> 694,144 <PP&E> 269,038 <DEPRECIATION> 86,487 <TOTAL-ASSETS> 924,715 <CURRENT-LIABILITIES> 135,089 <BONDS> 56,960 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 741 <OTHER-SE> 717,872 <TOTAL-LIABILITY-AND-EQUITY> 924,715 <SALES> 394,863 <TOTAL-REVENUES> 557,587 <CGS> 62,144 <TOTAL-COSTS> 74,509 <OTHER-EXPENSES> 292,439 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 5,945 <INCOME-PRETAX> 210,193 <INCOME-TAX> 71,496 <INCOME-CONTINUING> 138,697 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 138,697 <EPS-PRIMARY> 1.88 <EPS-DILUTED> 1.80